Using tumours from multiple-case breast cancer families with on average later age at onset than in our series, Lakhani et al (1998 and 2002) carried out similar studies to ours to try to identify BRCA1 mutation carriers on the basis of pathology and immunohistochemistry. This evidence concerns the gene BRCA1 and neoplasm.